$RLFTF Interesting opinion post (copy) by Joshua on ya-hoo 2 hours ago
I would be lying if I didn’t say I’ve been a bit frustrated with the company. For many here it seems like the company has been withholding information from shareholders. It seems to have had a negative effect on the SP, which is why we have been irritated when some of that news has been revealed to us.
But if we look deeper we can see that the company is not simply withholding bad news, they are also withholding the good stuff. Look no further then NeuroRX’s presentation to Big Rock. Specifically I would like to point to slides #17 and 18. The highlights
-Inhaled Aviptadil trial initiated with Covance in December.
-Contract signed to supply drug to I-Spy
clinical trial platform led by Quantam Leap Healthcare Collaborative
-Inclusion in NIH TESICO/Activ3b trial
This information is extremely positive stuff, but was never shared via PR by Relief. Why? Well...
NeuroRX and Relief are separate companies, so it makes disclosing information to shareholders quite interesting. These moves/transactions listed on slides 17 and 18 are the work of NeuroRX, not Relief. But the reality is they have a similar goal. They both want Aviptadil to be granted EUA and full approval so that it can help people and make the companies money. The fate of both companies are very much tied to Aviptadil. NeuroRX expanding to a publicly traded company has made that move with Aviptadil as a very important part of that transaction (see slide #4).
And so we complain about getting bad PR, or lack of PR, but the company is obviously not sharing all the information with us. It seems there are lots of good things going on in the background and since much of that is happening in the US (NeuroRX’s territory and not necessarily Reliefs) we have been left in the dark. But if we look deeper and examine the info we can find the bread crumbs.
NeuroRX didn’t lie in their investor presentation to Big Rock. Lots of good stuff happening we don’t even know about and believe me NeuroRX is very much invested in the success of Aviptadil. They are working very hard to get this to market and I trust Javitt and the gang will get it there. GLTA
I would be lying if I didn’t say I’ve been a bit frustrated with the company. For many here it seems like the company has been withholding information from shareholders. It seems to have had a negative effect on the SP, which is why we have been irritated when some of that news has been revealed to us.
But if we look deeper we can see that the company is not simply withholding bad news, they are also withholding the good stuff. Look no further then NeuroRX’s presentation to Big Rock. Specifically I would like to point to slides #17 and 18. The highlights
-Inhaled Aviptadil trial initiated with Covance in December.
-Contract signed to supply drug to I-Spy
clinical trial platform led by Quantam Leap Healthcare Collaborative
-Inclusion in NIH TESICO/Activ3b trial
This information is extremely positive stuff, but was never shared via PR by Relief. Why? Well...
NeuroRX and Relief are separate companies, so it makes disclosing information to shareholders quite interesting. These moves/transactions listed on slides 17 and 18 are the work of NeuroRX, not Relief. But the reality is they have a similar goal. They both want Aviptadil to be granted EUA and full approval so that it can help people and make the companies money. The fate of both companies are very much tied to Aviptadil. NeuroRX expanding to a publicly traded company has made that move with Aviptadil as a very important part of that transaction (see slide #4).
And so we complain about getting bad PR, or lack of PR, but the company is obviously not sharing all the information with us. It seems there are lots of good things going on in the background and since much of that is happening in the US (NeuroRX’s territory and not necessarily Reliefs) we have been left in the dark. But if we look deeper and examine the info we can find the bread crumbs.
NeuroRX didn’t lie in their investor presentation to Big Rock. Lots of good stuff happening we don’t even know about and believe me NeuroRX is very much invested in the success of Aviptadil. They are working very hard to get this to market and I trust Javitt and the gang will get it there. GLTA
1
Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ
